Novel Drugs, and Tech to Keep Ship Anchored, Lungs Breathing and Hands Strong win Venture Kick Support
17.06.2019
Innovations to set new standards in ship safety, treat brain tumors, help restore strength to hands, and keep intensive care patients breathing, each won 10,000 Swiss francs and coaching to develop their business ideas.
.jpg) |
 |
 Yago's co-founders Iselin Frøybu and Luca Randazzo
|
|
 MPC Therapeutics' co-founder Raphael Martinou and his father Jean-Claude Martinou.
|
|
 Swiss Ocean Tech's founder, MD and sales manager Thomas Frizlen
|
|
 STIMIT's founder Ronja Müller-Bruhn
|
|
Yago: a helping hand from a robotic glove
Yago is making a robotic glove to help people who have difficulty using their hands. Based on founder Lucca Randazzo’s doctoral research at EPFL’s Brain-Machine Interface lab, this spin-off uses a soft, motorized exoskeleton to help wearers grasp and release everyday objects. Randazzo hopes the patent-pending technology will restore users’ independence and autonomy in daily life.
Yago will use Venture Kick’s support will be used to test its market and business model assumptions with qualitative and quantitative market research.
yagoexo.com
MPC Therapeutics: novel drug for neurodegenerative diseases (University of Geneva)
Jean-Claude Martinou’s team from the University of Geneva discovered the molecular structure of mitochondrial pyruvate carrier and results suggesting its inhibition could treat Glioblastoma brain tumors, Parkinson’s Disease and liver diseases. Co-founders Raphael Martinou and Benjamin Perry are now developing first-in-class MPCinhibitor treatments for these diseases, for which no treatments are currently sold. The University of Geneva spin-off's proposed therapy has already attracted attention from Novartis. MPC Therapeutics will conduct further research and screening with a European partner.
Swiss Ocean Tech: Safe Anchoring Monitoring
Swiss Ocean Tech founder Thomas Frizlen wants to make anchored ships safer. He’s aiming to develop the world’s first monitor to warn sailors when their anchor is dragging, and prevent damaging collisions and groundings. The startup’s patented technology may set a new standard for maritime safety. The next landmarks: market testing, seed investors, and strengthening the founding team.
swissoceantech.com
STIMIT: a non-invasive diaphragm stimulator
STIMIT founder Ronja Müller-Bruhn is developing a device to help patients in intensive care breathe. Her simple, removeable, non-invasive and user-friendly tool activates the diaphragm to help people breathe during their first days of ventilation in hospital, when muscle inactivity can quickly cause complications. STIMIT plans to bring its first product, to be used by intensive care nurses, to market next year.
Venture Kick’s support will be used will be used to build, document and test a prototype.
stimidget.com
Yago is making a robotic glove to help people who have difficulty using their hands. Based on founder Lucca Randazzo’s doctoral research at EPFL’s Brain-Machine Interface lab, this spin-off uses a soft, motorized exoskeleton to help wearers grasp and release everyday objects. Randazzo hopes the patent-pending technology will restore users’ independence and autonomy in daily life.
Yago will use Venture Kick’s support will be used to test its market and business model assumptions with qualitative and quantitative market research.
yagoexo.com
MPC Therapeutics: novel drug for neurodegenerative diseases (University of Geneva)
Jean-Claude Martinou’s team from the University of Geneva discovered the molecular structure of mitochondrial pyruvate carrier and results suggesting its inhibition could treat Glioblastoma brain tumors, Parkinson’s Disease and liver diseases. Co-founders Raphael Martinou and Benjamin Perry are now developing first-in-class MPCinhibitor treatments for these diseases, for which no treatments are currently sold. The University of Geneva spin-off's proposed therapy has already attracted attention from Novartis. MPC Therapeutics will conduct further research and screening with a European partner.
Swiss Ocean Tech: Safe Anchoring Monitoring
Swiss Ocean Tech founder Thomas Frizlen wants to make anchored ships safer. He’s aiming to develop the world’s first monitor to warn sailors when their anchor is dragging, and prevent damaging collisions and groundings. The startup’s patented technology may set a new standard for maritime safety. The next landmarks: market testing, seed investors, and strengthening the founding team.
swissoceantech.com
STIMIT: a non-invasive diaphragm stimulator
STIMIT founder Ronja Müller-Bruhn is developing a device to help patients in intensive care breathe. Her simple, removeable, non-invasive and user-friendly tool activates the diaphragm to help people breathe during their first days of ventilation in hospital, when muscle inactivity can quickly cause complications. STIMIT plans to bring its first product, to be used by intensive care nurses, to market next year.
Venture Kick’s support will be used will be used to build, document and test a prototype.
stimidget.com